Validated predictive QSAR modeling of N-aryl-oxazolidinone-5-carboxamides for anti-HIV protease activity
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (20) , 6082-6087
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- On Some Aspects of Variable Selection for Partial Least Squares Regression ModelsQSAR & Combinatorial Science, 2008
- Discovery of HIV-1 Protease Inhibitors with Picomolar Affinities Incorporating N-Aryl-oxazolidinone-5-carboxamides as Novel P2 LigandsJournal of Medicinal Chemistry, 2006
- QSAR of adenosine A3 receptor antagonist 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives using chemometric toolsBioorganic & Medicinal Chemistry Letters, 2005
- Highly Active Antiretroviral Therapy: Current State of the Art, New Agents and Their Pharmacological Interactions Useful for Improving Therapeutic OutcomeCurrent Pharmaceutical Design, 2005
- Optimal QSAR analysis of the carcinogenic activity of drugs by correlation ranking and genetic algorithm‐based PCRJournal of Chemometrics, 2004
- The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR ModelsQSAR & Combinatorial Science, 2003
- Beware of q2!Journal of Molecular Graphics and Modelling, 2002
- QSAR modeling with the electrotopological state indices: CorticosteroidsJournal of Computer-Aided Molecular Design, 1998
- The Electrotopological State: An Atom Index for QSARQuantitative Structure-Activity Relationships, 1991
- Atomic physicochemical parameters for three dimensional structure directed quantitative structure‐activity relationships III: Modeling hydrophobic interactionsJournal of Computational Chemistry, 1988